Discover 2,414 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,414
Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
Sponsor: National Human Genome Research Institute (NHGRI)
Sex: All
Age: 0 - 70+
Code: NCT02890342
Recruiting
Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
for
Influenza Prevention, Seasonal Influenza
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 50
Code: NCT06863142
Phase1, Recruiting
Vaccine Responses in Patients With B Cell Malignancies
for
Lymphoma
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: All
Age: 18 - 70+
Code: NCT05170399
Recruiting
Characterization and Treatment of Adolescent Depression
for
Depression
Location: Bethesda MD
Sponsor: National Institute of Mental Health (NIMH)
Sex: All
Age: 11 - 25
Code: NCT03388606
Recruiting
Data Collection Study of Pediatric and Adolescent Gynecology Conditions
for
Disorders of Sex Development (DSD),
Location: Bethesda MD
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Sex: All
Age: 0 - 70+
Code: NCT04717349
Recruiting
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
for
ACTH, Cushing's Syndrome
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 18 - 70+
Code: NCT02019706
Phase2, Recruiting
Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
for
HIV
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05419024
Phase2, Recruiting
A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
for
Neuroendocrine Carcinomas, Neuroendocrine Tumors,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT06041516
Phase1, Recruiting
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer